JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women

Background: Polycythemia Vera (PV) is a myeloproliferative neoplasm (MPN) characterized by the overactivity of erythroid progenitors, leading to excessive red blood cell (RBC) production. More than 90% of PV cases harbor a Janus kinase 2 (JAK2) gene mutation. This study aimed to assess the prevalenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeinab Siahmargoie, Mohammad Taher Hojjati, Hadi Bazzazi, Khodaberdi Kalavi, Mana Zakeri, Hadi Joshaghani
Format: Article
Language:English
Published: Golestan University of Medical Sciences 2025-03-01
Series:Medical Laboratory Journal
Subjects:
Online Access:http://mlj.goums.ac.ir/article-1-1743-en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388434574016512
author Zeinab Siahmargoie
Mohammad Taher Hojjati
Hadi Bazzazi
Khodaberdi Kalavi
Mana Zakeri
Hadi Joshaghani
author_facet Zeinab Siahmargoie
Mohammad Taher Hojjati
Hadi Bazzazi
Khodaberdi Kalavi
Mana Zakeri
Hadi Joshaghani
author_sort Zeinab Siahmargoie
collection DOAJ
description Background: Polycythemia Vera (PV) is a myeloproliferative neoplasm (MPN) characterized by the overactivity of erythroid progenitors, leading to excessive red blood cell (RBC) production. More than 90% of PV cases harbor a Janus kinase 2 (JAK2) gene mutation. This study aimed to assess the prevalence of JAK2 mutations in individuals with elevated hemoglobin (Hb) levels referred to the laboratory by physicians. Methods: In this descriptive cross-sectional study, genomic DNA from 72 patients was analyzed for JAK2 mutations using a TaqMan-specific probe. Results: Of the 72 patients, 24 (33.3%) were women and 48 (66.6%) were men. JAK2 mutations were detected in 33 cases (45.5%), while 39 (54.2%) were negative. Notably, 15 of 24 female patients (62.5%) tested positive for the JAK2 mutation, compared to 18 of 48 male patients (37.5%). Conclusion: Our findings suggest that screening for JAK2 mutations is particularly important in women with above-normal Hb levels.
format Article
id doaj-art-a35d5abfbc5040678170d7091cb3f2ec
institution Kabale University
issn 2538-4449
language English
publishDate 2025-03-01
publisher Golestan University of Medical Sciences
record_format Article
series Medical Laboratory Journal
spelling doaj-art-a35d5abfbc5040678170d7091cb3f2ec2025-08-20T03:42:18ZengGolestan University of Medical SciencesMedical Laboratory Journal2538-44492025-03-011923033JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged womenZeinab Siahmargoie0Mohammad Taher Hojjati1Hadi Bazzazi2Khodaberdi Kalavi3Mana Zakeri4Hadi Joshaghani5 Iranian Blood Transfusion Organization, Gorgan Branch, Iran Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran Department of Medical Genetics, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran Background: Polycythemia Vera (PV) is a myeloproliferative neoplasm (MPN) characterized by the overactivity of erythroid progenitors, leading to excessive red blood cell (RBC) production. More than 90% of PV cases harbor a Janus kinase 2 (JAK2) gene mutation. This study aimed to assess the prevalence of JAK2 mutations in individuals with elevated hemoglobin (Hb) levels referred to the laboratory by physicians. Methods: In this descriptive cross-sectional study, genomic DNA from 72 patients was analyzed for JAK2 mutations using a TaqMan-specific probe. Results: Of the 72 patients, 24 (33.3%) were women and 48 (66.6%) were men. JAK2 mutations were detected in 33 cases (45.5%), while 39 (54.2%) were negative. Notably, 15 of 24 female patients (62.5%) tested positive for the JAK2 mutation, compared to 18 of 48 male patients (37.5%). Conclusion: Our findings suggest that screening for JAK2 mutations is particularly important in women with above-normal Hb levels.http://mlj.goums.ac.ir/article-1-1743-en.pdfpolycythemia verajak2 proteinhumanmutationhemoglobinswomen
spellingShingle Zeinab Siahmargoie
Mohammad Taher Hojjati
Hadi Bazzazi
Khodaberdi Kalavi
Mana Zakeri
Hadi Joshaghani
JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
Medical Laboratory Journal
polycythemia vera
jak2 protein
human
mutation
hemoglobins
women
title JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
title_full JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
title_fullStr JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
title_full_unstemmed JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
title_short JAK2 mutation, a potential cause of increasing Hemoglobin levels in symptomatic aged women
title_sort jak2 mutation a potential cause of increasing hemoglobin levels in symptomatic aged women
topic polycythemia vera
jak2 protein
human
mutation
hemoglobins
women
url http://mlj.goums.ac.ir/article-1-1743-en.pdf
work_keys_str_mv AT zeinabsiahmargoie jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen
AT mohammadtaherhojjati jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen
AT hadibazzazi jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen
AT khodaberdikalavi jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen
AT manazakeri jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen
AT hadijoshaghani jak2mutationapotentialcauseofincreasinghemoglobinlevelsinsymptomaticagedwomen